Taken together, these data sustain that the pharmacological inhibition of CA-IX allows a meaningful increase of cell death and a decrease of aggressiveness and metastatic potential of tumor cells, verified also through the expression of apoptotic markers and the EMT pathway. This evidence concerns the gene CA9 and neoplasm.